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REVIEW

Sporadic worldwide “clusters” of feed driven
Zilpaterol identifications in racing horses:
a review and analysis
Jacob Machin1, Kimberly Brewer2, Abelardo Morales‑Briceno3, Clara Fenger4, George Maylin5 and
Thomas Tobin1*

Abstract
Zilpaterol is a β2-adrenergic agonist medication approved in certain countries as a cattle feed additive to improve
carcass quality. Trace amounts of Zilpaterol can transfer to horse feed, yielding equine urinary “identifications” of Zil‑
paterol. These “identifications” occur because Zilpaterol is highly bioavailable in horses, resistant to biotransformation
and excreted as unchanged Zilpaterol in urine, where it has a 5 day or so terminal half-life.
In horses, urinary steady-state concentrations are reached 25 days (5 half-lives) after exposure to contaminated feed.
Zilpaterol readily presents in horse urine, yielding clusters of feed related Zilpaterol identifications in racehorses. The
first cluster, April 2013, involved 48 racehorses in California; the second cluster, July 2013, involved 15 to 80 racehorses
in Hong Kong. The third cluster, March 2019, involved 24 racehorses in Mauritius; this cluster traced to South African
feedstuffs, triggering an alert concerning possible Zilpaterol feed contamination in South African racing. The fourth
cluster, September/October 2020 involved 18 or so identifications in French racing, reported by the French Laborato‑
ries des Courses Hippiques, (LCH), and in July 2021, a fifth cluster of 10 Zilpaterol identifications in South Africa.
The regulatory approach to these identifications has been to alert horsemen and feed companies and penalties
against horsemen are generally not implemented. Additionally, given their minimal exposure to Zilpaterol, there is
little likelihood of Zilpaterol effects on racing performance or adverse health effects for exposed horses.
The driving factor in these events is that Zilpaterol is dissolved in molasses for incorporation into cattle feed. Inadvert‑
ent incorporation of Zilpaterol containing molasses into horse feed was the source of the California and Hong Kong
Zilpaterol identifications. A second factor in the 2019 Mauritius and 2020 French identifications was the sensitivity of
testing for Zilpaterol in Mauritius and France, with the French laboratory reportedly testing at a “more sensitive level for
Zilpaterol”. As of January 1st, 2021, the new FEI Atypical Finding (ATF) policy specifies Zilpaterol as a substance to be
treated as an Atypical Finding (ATF), allowing consideration of inadvertent feed contamination in the regulatory evalu‑
ation of Zilpaterol identifications.
Keywords: Horses, Feed, Zilpaterol, Inadvertent transfer, Urine, Limit of Detection (LOD), Worldwide clusters
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Background
Zilpaterol,
( ±)-trans-4,5,6,7-Tetrahydro-7-ydroxy6-(isopropylamino)-imidazo[4,5,1-jk]-[1]benzazepin2(1H)-one, C14H19N3O2, molar mass, 261.325, Fig. 1
below, is a β2-adrenergic agonist approved in a number of countries as a cattle feed additive, where it
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Fig. 1 Zilpaterol, Clenbuterol and Albuterol, structurally related β2-agonists: Zilpaterol, ( ±)-trans-4,5,6,7-Tetrahydro-7-h
ydroxy-6-(isopropylamino)-imidazo[4,5,1-jk]-[1]benzazepin-2(1H)-one, formula, C
 14H19N3O2, molar mass 261.325 g/mol. Zilpaterol contains two chiral
carbons, carbons 6 and 7, giving rise to four enantiometic forms of Zilpaterol, (6R,7R), (6R,7S), (6S,7R). (6S,7S). Zilpaterol is marketed as Zilmax [3], a
racemic mixture of the pharmacologically active 6R,7R eutomeric β2-agonist isomer and also the 6S,7S enantiomer.

promotes weight gain and improves carcass quality
[1]. The recent reporting of 18 or so feedstuff related
low concentration identifications of Zilpaterol in
urine samples from racing horses by the French racing laboratory, Laboratory des Courses Hippiques
(LCH) [2] and previous clusters of Zilpaterol identifications elsewhere (Table 1, below) have given rise to
questions related to the origins of such identifications,
the possibility or otherwise of performance effects on
racing horses and also any short or long term equine
health consequences related to such low concentration
exposures.
In equine forensic science a “cluster” is defined as at
least three identifications of the same substance in the

large numbers of unrelated horses/trainers in defined
locations and time frames. The concentrations of the
substance involved in such clusters are also likely to
be pharmacologically irrelevant, a further indication
that these trace level identifications of Zilpaterol are
not trainer associated, as is the case in these current
matters.
In the absence of defined regulatory “cut-offs” for the
detection of Zilpaterol, horsemen competing under these
regulatory conditions require guidance for determining
the time post-withdrawal of affected feed for a horse testing “positive” for Zilpaterol to go analytically “negative”
[5, 6]. Addressing these concerns, we have reviewed the
available data on urinary concentrations of Zilpaterol

Table 1 Feed related clusters of equine zilpaterol identifications
Year

Country

Horses Detection

Control Authority

Lab

Horse Feed

Penalty

March April 2013 USA California

48

Post-Race

California CHRB

University of Cali‑
fornia, Davis

1- US Brands

No Trainer Penalties

June
2013

80 plus

Pre-Race

Hong Kong Jockey
Club (HJKC)

HKJC Lab

2 US Brands

No Trainer Penalties

Hong Kong

2019

Mauritius

24

Out of Competition Mauritius Turf Club

QuantiLAB

South African No Trainer Penalties

2020

France

18

Post-Race

France Galop, Le
Trot

LCH France

Irish

July
2021

Republic of South
Africa

10

Post-Race

National Horseracing Authority
(NHA)

National Horseracing Authority

South African 1 Trainer guilty, 7
trainers retained
counsel

No Trainer
Penalties

Feedstuff related clusters of Zilpaterol identifications, 2013→2021, Dates of events, Jurisdiction, Number of cases reported, Pattern of testing, Authority, Laboratory,
Source of Feed and Penalties. In Hong Kong 16 horses were initially identified but there were suggestions that at least 80 more horses had been exposed. In the 2020
events 18 horses were withdrawn from racing in England and France because of exposure to Zilpaterol containing horse feed

same geographic area and time frame in horses from
three or more independent trainers [4]. This definition
is based on the unlikelihood of three unrelated trainers independently and simultaneously deciding to use
the same inappropriate substance in their racing horses.
These reviewed Zilpaterol identifications readily meet
this definition, in that these clusters involve relatively

in horses and other animals in order to determine the
pharmacological and toxicological significance of trace
level identifications of Zilpaterol in equine urines and the
time required for such horses/urines to go analytically
“negative”. We will begin this analysis with a review of the
chemical structure of Zilpaterol and its pharmacology
and pharmacokinetics in horses and other species.
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The unique chemical structure of Zilpaterol

substantially for day 2 in these horses. These experimental
data are therefore based on this two dose administration,
resulting in high initial urinary concentrations of Zilpaterol, on the order of 10,000 nanograms per ml in urine.
These findings are consistent with rapid and complete
absorption of Zilpaterol as well as the adverse responses
seen in these experimental horses. The data from Shelver
et al. are consistent with a two-compartment Zilpaterol
urinary elimination model, as in equation #1 below:

Zilpaterol was synthesized for use as an oral β2-agonist
feed additive administered to cattle over periods of several weeks [1]. It is therefore useful if the molecule is 1/
well absorbed orally and, 2/ has a long plasma half-life,
i.e., remains present as the pharmacologically active substance in the blood stream of treated animals. Zilpaterol
meets both of these requirements, making it a useful partitioning agent and it is currently approved for such use
in cattle in the US, Canada, Brazil, Colombia, Costa Rica,
Dominican Republic, Guatemala, Honduras, Kazakhstan,
Mexico, Nicaragua, Panama, Peru, South Africa, South
Korea, and the Ukraine [1, 3].
Pharmacokinetics and pharmacodynamics of Zilpaterol

Zilpaterol, Fig. 1 above, meets these pharmacological
requirements by virtue of its chemical structure. Zilpaterol is unique among marketed β2-agonists in that the
β2-agonist portions of the Zilpaterol molecule are held
in a specific configuration by the tricyclic ring structure
of Zilpaterol, [7] in comparison with the less constrained
structures of Clenbuterol and Albuterol, both of which
are more rapidly biotransformed [8, 9]. This chemical
structure apparently accounts for Zilpaterol’s rapid and
approaching 100% oral bioavailability [10] and its resistance to metabolic biotransformation, which results in a
prolonged 5 day or so terminal half-life of Zilpaterol in
equine urine, a pharmacokinetic fact that has important
regulatory implications.
The regulatory implications are that pharmacodynamically Zilpaterol presents as a classic β2-agonist partitioning agent with a considered ability to improve muscle
mass and thereby potentially enhance athletic performance or yield a competitive advantage. This analysis
has led to a number of regulatory organizations to ban
Zilpaterol completely in animals and humans (ARCI
2018, WADA, 2018). As a practical matter, this meant
that prior to January 2021 any detection of Zilpaterol in
a racing sample initiated regulatory review under a zero
tolerance Zilpaterol detection policy, including detection
of low picogram/ml concentrations of Zilpaterol in postrace urine samples.
Urinary pharmacokinetics Zilpaterol

The best available data on post administration equine
urinary concentrations of Zilpaterol are those of Shelver
and colleagues [10–13]. In their equine experiments Zilpaterol was administered at the recommended food animal
dose of 0.17 mg/kg of body weight, for a total daily dose
of about 70 mg per horse to three horses weighing about
470 kg. Because these dosed horses immediately showed
adverse clinical responses [10, 14], namely increased heart
rate, tremors and profuse sweating, the dose was reduced

8967.436e−1.32202t + 13.86484e−0.13597∗t

(1)

This pharmacokinetic model was calculated by curve
stripping of the mean data set and describes a multi−exponential decay model showing biphasic elimination kinetics
as described by Dunne et al., [15]. The initial rapid phase
shows a urinary elimination half−life of about 13.2 h, followed by a second much slower and apparently terminal
urinary elimination half−life of around 120.7 h, or close to
5 days, as in Fig. 2 below.
The initial urinary half-life of about 13.28 h is observed
for the first 5 days post administration. Then, starting
about day 6 post administration, the slower and presumably terminal phase urinary half-life presents, with
an apparent terminal half-life of about 121 h or close to
5 days. In these experiments Zilpaterol remained detectable in urine at about the one nanogram per milliliter
Limit of Detection (LOD) of the analytical methodology
for the full 21 days of this experiment. We also note that
this 1 nanogram/ml urinary concentration is a full 10,000
fold below the peak plasma concentrations achieved in
these horses and which plasma concentrations produced
clear pharmacological responses.
Consistent with the observed adverse clinical responses
in these horses, the initial urinary concentrations of Zilpaterol were estimated at about 10 times the concentrations reported in bovines and sheep [11–13] and 100
times the concentrations reported in pigs [13]. The basis
of the pharmacokinetic differences between these species is unclear, but it is apparent that administered as a
one-time oral dose, Zilpaterol is rapidly and completely
absorbed by the horse, yields higher than expected
plasma concentrations as judged by the adverse clinical
responses reported, and is also excreted initially at relatively high concentrations in equine urine [10, 14]. These
data show that for reasons which presumably relate to
the anatomical and physiological differences between
the equine and ruminant digestive tracts, that the equine
foregut rapidly and essentially completely absorbs Zilpaterol, in contrast with its initial dilution in the rumen
of cattle and sheep. The take home message at this point
is that in the horse Zilpaterol administered orally is rapidly and completely absorbed.
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Fig. 2 Mean urinary concentrations of Zilpaterol post 0.17 mg/kg (~ 70 mg/horse) PO., replotted from Shelver et al [10]. The individual horses
are represented by the teal, orange, and grey lines, and symbols. Mean values of the three horse data set are represented by the yellow circles
and dashed line, with standard deviation of the groups at each timepoint represented by the black bars. The dark blue circles represent our
pharmacokinetic model, calculated by curve stripping of the mean dataset to determine a multi-exponential decay model showing biphasic
elimination. The first phase has a calculated half-life of 13.2 h, while the much slower terminal phase has a calculated half-life of 120.7 h, with the
transition between these domains at approximately 6 days post treatment

The second take home message from these data is that
the terminal urinary half-life of Zilpaterol in the horse
is relatively prolonged [10], at five days or so, which
has important implications for the urinary detection
of Zilpaterol following daily exposure of horses to trace
amounts in feed, as we will now detail.
Zilpaterol exposure and urinary Zilpaterol concentrations

The Shelver equine studies [10–13] demonstrate the pharmacokinetic profile of Zilpaterol after a two dose regimen,
which is unlikely to reflect the exposure of horses in our
described “clusters” of urinary identifications resulting
from ongoing trace level dietary exposure. To our knowledge the only available data on ongoing trace level dietary
exposure in any animal are those of Smith et al., 2019,
who studied the relationship between dietary exposure to
trace amounts of Zilpaterol and urinary concentrations in
sheep [12]. In these experiments, sheep were administered
Zilpaterol in feed at total daily doses of 13 µg, 130 µg and
1,300 µg or 1.3 mg/day/sheep for 12 days. The mean weight
of these sheep was fractionally above 50 kg/sheep, or about
10% of the weight of an adult horse. Each of these daily
administration protocols resulted in readily detectable peak
urinary concentrations of Zilpaterol, reported as 2.8 ng/

ml for the low dose, 21.4 ng/ml for the medium dose and
218 ng/ml for the high dose, these urinary concentrations
relating directly to the daily dose of Zilpaterol, as specifically noted by Smith and his colleagues. Given the approximately tenfold body mass difference between a sheep and a
horse, exposure to the low 13 mcg daily dose administered
to these sheep may be expected to yield 280 pg/ml urinary
Zilpaterol concentration in a horse, assuming that sheep
and horses handle Zilpaterol broadly similarly, and which
urinary concentrations are readily detectable by modern
racing chemistry laboratories.
The forensic significance of the longer terminal urinary
half‑life of Zilpaterol

Horses exposed to Zilpaterol in feed are likely to present steady state urinary concentrations of Zilpaterol,
because contaminated feed produced and purchased
in batches is likely to be consumed over the course of
many days. Maximal steady state urinary concentrations
of Zilpaterol will be achieved after five urinary halflives or about 25 days of daily exposure to Zilpaterol.
Because Zilpaterol is completely absorbed orally, is not
significantly metabolized, and is slowly eliminated by the
horse, urinary concentrations of Zilpaterol will increase
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post exposure, peaking at this 25 day mark. By day 25 or
so the amount of Zilpaterol eliminated each day is equivalent to the amount being absorbed and will be the highest urinary concentration of Zilpaterol associated with
that particular dose / feed exposure level. Then, when
exposure to the Zilpaterol containing feedstuff ceases,
the urinary concentrations of Zilpaterol will decline, following this same characteristic 5 day or so terminal urinary half-life.
Significance of overall Zilpaterol pharmacokinetics

These equine Zilpaterol pharmacokinetics immediately explain the events underlying the Table 1 reported
clusters of trace level Zilpaterol identifications following exposure of horses to trace amounts of Zilpaterol in
equine feedstuffs. First, Zilpaterol is highly bioavailable,
one of the few substances listed as 100% orally bioavailable, consistent with the rapid and complete absorption
of orally administered Zilpaterol in the Shelver horse
experiments [10]. Second, and unusually, Zilpaterol is not
significantly metabolized by the horse, also consistent
with the high initial urinary concentrations of Zilpaterol
post administration. This resistance to metabolism is also
consistent with the third unusual aspect of Zilpaterol in
horses, namely the relatively long terminal plasma halflife of Zilpaterol in the horse. Together, these pharmacokinetic characteristics give rise to the ongoing feed
related trace level exposure to Zilpaterol and resulting
“cluster” identifications across multiple racing jurisdictions worldwide.
The time required for a Zilpaterol “positive” urine to go
“negative”

Important to horsemen competing in regulatory environments in the absence of a regulatory threshold to control
environmental-source Zilpaterol is the time required
after Zilpaterol exposure ceases for a Zilpaterol “positive” urine to go analytically “negative”. The answer to
this question is variable since it depends on, 1) the concentration of Zilpaterol in the horses’ urine at the time
that exposure to Zilpaterol ceases and 2) the sensitivity,
technically the Limit of Detection [LOD] of the analytical method in use by the testing laboratory [5, 6]. In the
absence of information as to the concentration present
in the urine sample at the time of identification of the
problem and the fact that equine drug testing laboratories are usually reluctant to share their in place Limits of
Detection [LOD] for substances such as Zilpaterol, withdrawal time estimates may be little more than educated
estimates. Furthermore, as per the Irish Horseracing
Regulatory Board (IHRB), October 16th, 2020, communication, [2, 16] some laboratories may be “operating to
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a more sensitive level for Zilpaterol” [2] than others, adding to the uncertainly associated with such estimates. In
this regard, the most practical option is elective testing,
which allows one to determine whether or not the sample in question is Zilpaterol “positive” or “negative” as per
the testing technology of the laboratory performing the
analysis.
The role of testing sensitivity in these matters

It is an analytical fact of life that for a substance such
as Zilpaterol equine drug testing laboratories do not all
function at the same level of testing sensitivity. With
respect to these clusters of Zilpaterol identifications, this
differential in testing sensitivity first became apparent in
association with the 2019 cluster of Zilpaterol identifications in Mauritius [17]. This is because the sensitive testing in place in the Mauritius Laboratory, QuantiLAB Ltd,
was detecting urinary Zilpaterols traced to horse feeds
originating in South Africa [18]. This identification by
the Mauritius laboratory of Zilpaterol in South African
horse feeds apparently led to a communication to horsemen by the South African National Horseracing Authority (NHA) concerning the possible presence of Zilpaterol
in South African horse feeds. Additionally, to our knowledge as of July 2021 the first Zilpaterol “positives” have
been called in South African racing, with 10 Zilpaterol
identifications from 8 trainers recently reported in South
African racing [19].
A similar inter-laboratory differential in Zilpaterol
testing sensitivity is apparent in the recent French 2020
cluster of Zilpaterol identifications, where Zilpaterol
identifications in regulatory samples were reported
only by the French LCH laboratory, and not by the English LGC laboratory analyzing British and Irish racing
and Fédération Èquestre Internationale (FEI) samples.
Reportedly, as in Table 2 above, the LGC laboratory
does not report Zilpaterol at urinary concentrations
of less than 250 picograms/ml, while the French LCH
laboratory reports Zilpaterol down to 100 picograms/
ml, a 2.5 times more sensitive test. This more sensitive
testing by the LCH laboratory presumably accounts for
the fact that horses consuming potentially Zilpaterol
containing feeds have not been reported as producing
Zilpaterol containing urines in English and Irish equine
drug testing, while there have been a number of such
identifications reported in French regulatory testing
(Table 1). Other fallout from these 2020 French events
included 11 horses being withdrawn from the 2020
Prix de l’Arc de Triomphe in October 2020 [20], and a
trainer in England withdrawing 7 runners, all associated with exposure or potential exposure to Zilpaterol
contaminated feed.
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Table 2 Laboratories associated with the french 2020 Zilpaterol cluster
Lab Name

Lab ISO 17025 Method Used Is
Matrix in Scope
Accredited
LC–MS-MS in Scope

Limit of Detection

LGC- Newmarket, UK and IHRB Analytical Laboratory
Also reference lab on France Gallop list of Approved Labs

Yes

Yes

Water
Liver
Urine

1 ppb
1 ppb
0.25 ppb

Irish Equine Centre, Co. Kildare

Yes

Yes

Urine ( Bovine)

1 ppb

DAFM, Backweston, Co Kildare

Yes

Yes

Feed

50 ppb

Independent Equine Nutrition Mildenhall, UK
Dr. Mark Dunnett

No

No

Feed

1–10 ppb as conducted
negative controls on samples

LCH Verrieres-le-Buisson, France

Yes

Yes

Urine

0.1 ppb (as reported)

NHA Laboratory

Yes

Yes

Urine

Not Reported

Testing laboratories involved in the 2020 French Zilpaterol Cluster and best available estimates of Zilpaterol testing sensitivities linked to the 2020 Zilpaterol cluster,
sensitivity reported as parts per billion (ppb) in urine. Irish/British racing samples were tested at the LGC laboratory and the French racing/equine samples were tested
at Laboratories des Courses Hippiques, (LCH). Samples were also tested at the Irish Equine Center (IEC) laboratory, the Backweston laboratory of the Irish Department
of Agriculture, Food, and the Marine (DAFM), and Independent Equine Nutrition (IEN) Laboratory, Mildenhall, UK. Best available information is that the Limit of
Detection for LCH Zilpaterol urine testing was in the order of 100 pg/ml, 2.5 times more sensitive than that of LGC Newmarket

These trace level Zilpaterol identifications are most likely
without pharmacological or toxicological significance
for the horses involved

The final question with regard to these clusters of Zilpaterol identifications is their significance for the health,
welfare, and racing performance of the involved horses.
The answer to this question is clear; given the low daily
mcg amounts of Zilpaterol to which these horses have
been exposed, in the order of 1/4,000 or less than a pharmacologically effective dose, the likelihood of significant adverse health effects, either short or long term is,
as a practical matter, indistinguishable from zero. In this
regard the European Union Joint Expert Committee on
Food Additives [JECFA] [21] derived an acceptable daily
intake of Zilpaterol for humans of 0.04 µg per kilogram
body weight, or a total daily dose for human of about
2.8 µg per day, or about 17 ug/day for a horse [6]. These
dosage levels, based on acceptable human exposure rates,
are on the same order of the15 ug/day or so total dose
of Zilpaterol to which the horses in the most recent 2020
French cluster of racing chemistry Zilpaterol “positives”
have been exposed. There is therefore as a practical matter, essentially no likelihood of adverse effects on these
animals related to the Zilpaterol exposure giving rise to
these low concentration French racing chemistry “positive” urinary identifications. Similarly, there is also no significant possibility of an effect on the racing performance
of horses exposed to these extremely small amounts of
Zilpaterol.
Cluster events case reports

These data and analyses show that Zilpaterol has chemical and pharmacokinetic characteristics that result in its
presence at detectable concentrations in equine urine
samples even though the horses have only been exposed

to daily microgram amounts of Zilpaterol. In these situations, dietary exposure to small daily intakes of Zilpaterol
can give rise, over a matter of 2–4 weeks, to racetrack
testing detectable urinary concentration of Zilpaterol,
i.e., potential Zilpaterol “positives’, as we will now detail
[2].
California, 2013

The first well characterized Zilpaterol identification
cluster took place in March / April 2013 in California Racing, where a number of US feed products from
a California plant inadvertently came to contain small
amounts of Zilpaterol. This Zilpaterol began to show
up in racing horses, apparently about two weeks after
their first exposure to the affected feed, consistent with
the urinary accumulation time course set forth above. A
total of 48 horses were reported “positive” for Zilpaterol
before the source was identified and the problem remedied. The California racing authorities also recognized
that the horsemen involved were entirely innocent and
our understanding is that no regulatory action was taken
against the affected horsemen [22, 23].
Hong Kong, 2013

Soon thereafter, in July 2013, a similar Zilpaterol identification cluster unfolded in Hong Kong, where at least
16 horses were reported as testing positive for Zilpaterol.
The source of Zilpaterol was again traced to feed and
since the horses were racing at Hong Kong Jockey Club
(HKJC) tracks, the feed had been provided via the Hong
Kong Jockey Club itself. The total number of Zilpaterol
identifications reported in this Hong Kong cluster was
16, although there have been suggestions that a larger
number, possibly 80 or so other horses racing at Hong
Kong, may have been exposed. Additionally, and quite
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interestingly, we understand that the feed products causing these Hong Kong identifications had become contaminated from the same Zilpaterol source as the earlier
California identifications, with the time delay between
the California and Hong Kong identifications reflecting
transpacific shipping time [24, 25].
Mauritius, 2019

The next cluster of Zilpaterol identifications was in
March 2019, when the racing stewards of the Mauritius
Turf Club reported that Zilpaterol had been detected in
Out Of Competition (OOC) urine samples taken from
24 horses from 7 different stables. The Stewards considered that it was beyond reasonable doubt that the horses
had tested positive for Zilpaterol as a result of feed contamination, so no action was taken against the affected
trainers. In a later communication, dated November
25th, 2019, the Mauritius Turf Club authorities reported
that an investigation had concluded that the most likely
source of these Zilpaterol identifications was feed originating in South Africa [26, 27].
Shortly before the Mauritius Turf Club authorities
released their November 25th, 2019 report, concerns
about possible Zilpaterol detections in racing horses
in South Africa were communicated, although to our
knowledge no formal “positive” identifications were
“called”. On November 8th 2019 the South African Sporting Post noted that the National Horseracing Authority [NHA] in South Africa, in an unsigned and undated
notice, stated that “in some racehorse specimens emanating countrywide, traces of a substance which may
be indicative of Zilpaterol”, effectively communicating
the possible presence / detection of Zilpaterol in South
African racing samples [16]. This communication was
greeted with concern by South African trainers, who
were unclear as to what the South African NHA expected
the trainers to do, besides contacting their feed merchants and requesting confirmation, which may well have
been the reason for the NHA communication [18, 28,
29]. We also note that these Zilpaterol concerns in South
African racing are fully consistent with approval of Zilpaterol for use in cattle feed in South Africa and the now
well understood ease with which Zilpaterol can inadvertently transfer in microgram amounts from livestock
industry sources to horse feed and thereby to post-race
urine samples.
France 2020

The 2020 cluster of Zilpaterol racing identifications
occurred in France, involving 12 France Galop Thoroughbred horses, 4 Le Trot Harness Horses and 2 horses from
trainer’s yards, we understand to date an 18 total samples,
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with the testing performed by the French Laboratory
des Course Hippiques (LCH) [30, 31]. The first samples
in which identifications were reported were collected
on or about August 30th, with the first identifications
of Zilpaterol reported by LCH on September 29th. The
apparent source of Zilpaterol in these samples has been
microgram amounts of Zilpaterol inadvertently incorporated into some horse feed products, the estimated
daily intake per horse being minimal, in the order of 15
ug/horse/day. This French Zilpaterol cluster is unusual in
that the identifications were reported only in France and
are associated only with LCH testing, even though the
feeds in question were also consumed by horses racing in
England and Ireland [32, 33]. This French Zilpaterol cluster is therefore forensically similar to the 2019 Mauritius
cluster, where the Mauritius Zilpaterol identifications
were traced to South African horse feeds, but these feeds
had apparently not drawn attention in South African racing until the more analytically sensitive Mauritius identifications were traced back to a South African horse feed
source.
South Africa, 2021

As this report was being drafted the National Horseracing Authority in South Africa has apparently elected to
call 10 Zilpaterol “positives” on 8 trainers in the KwaZulu-Natal province [19], apparently another classic
“cluster”. Seven of these trainers have retained counsel
and one trainer with two “positives” pleaded “not guilty”.
Despite the extensive worldwide precedents set forth
above, this trainer was found “guilty” by the NHA and
issued a warning. The downside for this trainer is that he
now has an Association of Racing Commissioners International (ARCI) Drug Class 2, Penalty Class A foreign
substance violation on his record, despite being to our
knowledge no more guilty of such a violation than any of
the other 100 or so trainers worldwide with similar feed
related trace level Zilpaterol “positives”.
Regulatory approaches to these Zilpaterol clusters

Reviewing these 2020 Zilpaterol cluster events, the International Federation of Horseracing Authorities (IFHA)
and the European Horseracing Scientific Liaison Committee, (EHSLC) have recommended that all horseracing
jurisdictions should offer elective testing for Zilpaterol
where feed contamination is suspected. This elective
testing should be performed in the country in which the
horse holds an entry, and no regulatory action should be
taken against any screening findings for Zilpaterol in an
elective test where it can be demonstrated that the horse
was likely fed contaminated feed [33]. The final recommendation was that working through the IFHA, racing
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jurisdictions and their analytical laboratories will work
together to harmonize the reporting limits for Zilpaterol
and other key substances which are prohibited at all
times.
With respect to the regulatory significance of these
clusters of Zilpaterol identifications, it is important to
note that to our knowledge no significant regulatory
actions have been taken against any of the horsemen
involved. [34] In the 2103 Hong Kong cases, triggered
by postrace identifications, the Hong Kong Jockey Club
stewards conceded the Zilpaterol finding was due to the
“feed product imported by the Club at the request of the
trainers,” “being contaminated” [35]. Given this circumstance, the trainer involved was not penalized, because
the stewards considered that the Hong Kong trainers
involved were innocent of any wrongdoing in these Hong
Kong Zilpaterol matters, although the Zilpaterol positive
horses were disqualified.
The concentrations of Zilpaterol involved in these
identifications are considered to be without pharmacological or forensic significance, and at times the amounts
detected are defined simply by the limit of sensitivity of
the testing in place in the testing laboratory question, as
in the 2019 Mauritius and 2020 French clusters. In the
Mauritius matter, the Mauritius Turf Club reported on
March 22nd, 2019, that “after due consideration, the Racing Stewards found, beyond reasonable doubt, that the
above horses had been tested positive for ‘Zilpaterol’ as a
result of feed contamination. [36]. Accordingly, no action
was taken against any one of the above trainers”. Similarly,
as reported by the Blood-Horse on March 27th, 2013, “the
California Horse Racing Board, citing feed contamination,
has dismissed all 48 positive tests for Zilpaterol”. [37].
Consistent with these rulings, the British Equestrian
Federation (BEF) on or about October 2
 4th, 2020, instituted “a 14 day moratorium over positive doping tests”.
During this moratorium any horse returning a positive
result for Zilpaterol will not be subjected to any regulatory action under the BEF anti-doping rules, provided
the positive sample is consistent with the feed being
contaminated with Zilpaterol [38]. This moratorium was
to be kept under review and was described as “may be
extended depended depending upon updating information relating to the contamination. Additionally, the British Equestrian Trade Association (BETA) indicated that
there were “no health or welfare issues in a horse consuming feed containing the level of Zilpaterol found. [36].
In a further response to these events, on the
23rd of November 2020, the Fédération Èquestre
Internationale[FEI] proposed a new analytical finding
category called an Atypical Finding (ATF) [39]. We note
that these Zilpaterol identifications meet each of the
ATF policy criteria recently presented by the FEI. As set
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forth in this policy, when reviewing a potential Adverse
Analytical Finding [AAF] for consideration as an Atypical Finding [ATF], the FEI will take a number of factors
into account, all of which factors are, to our knowledge,
met by the Zilpaterol identifications reviewed in this
communication.
These FEI ATF policy factors/criteria include a requirement that there be identifications of the same prohibited
substance arising from other samples taken at the relevant event(s), a criterion met by the various Zilpaterol
identifications clusters reported in this communication.
The second criterion is that there be ATF’s arising from
the same prohibited substance from other samples taken
in previous events held at the same venue and or in the
same region, which criterion is also very obviously met.
The third criterion is that samples taken from feed or
bedding at the relevant event test positive for the substance in question, which criterion has also been met by
these Zilpaterol identifications. The FEI also addresses
the matter of the concentration of the particular prohibited substance in the analytical samples which criterion
is to our knowledge also met in these Zilpaterol matters.
Finally, the new FEI Atypical Findings policy specifies
Zilpaterol as a prohibited substance that will be treated
as an Atypical Finding as of January 1st, 2021.

Conclusions
In closing, it appears that these horse racing Zilpaterol
cluster events have been driven in large part by a worldwide cattle feed manufacturing process. During cattle
feed manufacturing, Zilpaterol is incorporated into the
feed by dissolving it in the liquid molasses component of
the feed product. Inadvertent incorporation of Zilpaterol
containing molasses into horse feed has apparently been
the driving factor in each of these horse racing related
clusters of Zilpaterol identifications.
In the California horse racing identifications in the
spring of 2013 the source of the Zilpaterol contamination was identified as a Zilpaterol containing molasses
product intended for bovine use that inadvertently came
to contaminate the feedstuffs products involved in this
California matter. Then, at the same time as these California Zilpaterol identifications were being evaluated,
shipments of horse feeds similarly contaminated with
Zilpaterol containing molasses were in transit to Hong
Kong. These products arrived in Hong Kong a number of
weeks after the California sequence of Zilpaterol events
and three months later, gave rise to the sequence in Hong
Kong of Zilpaterol identifications.
The 2019 Mauritius cluster of Zilpaterol identifications were linked to South African feedstuffs, and the
2020 French identifications of Zilpaterol were also linked
to South Africa. Reviewing the 2020 French cluster, the
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Irish Department of Agriculture, Food and the Marine
(DAFM) noted that “The contamination was traced back
to a sugar mill in South Africa that operates with only one
blend tank at its feed site. This tank is used for blending
standardized molasses, containing zilpaterol, for the local
South African market. The blend tank was not sufficiently
cleaned for use of production of sugar cane molasses for
export and this resulted in a cross-contamination with
zilpaterol of sugar cane molasses exported to Ireland. The
necessary measures have been put in place to prevent/
avoid re-occurrence of such a cross-contamination” [40].
This South African shipment of molasses containing Zilpaterol also went to a significant number of English horse
feed companies as reported by the British Equestrian
Trade Association [41], although as noted, only horses
subjected to the higher sensitivity LCH French testing for
Zilpaterol were identified as regulatory “positive” identifications. South Africa is one of the countries in which the
use of Zilpaterol as a bovine feed additive has long been
approved, consistent with horse feed from South Africa
also being identified as the source of the 2019 Mauritius
Zilpaterol cluster and presumably also the most recent
2021 cluster of Zilpaterol identifications in South Africa.
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